基因编辑的全球市场 (2023～2030年):各技术、输送手法、方式、终端用户的规模、占有率、成长分析、预测

Global Genome Editing Market Size, Share, Growth Analysis, By Technology, By Delivery Method, By Mode, By End Use - Industry Forecast 2023-2030

出版日期: 2023年04月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

基因编辑的市场规模，2021年为48亿1,104万美元，2022年为58亿8,706万美元，从2023年到2030年的预测期间中预计以22.3％的年复合成长率发展，2030年成长到360亿6,095万美元的规模。

牵引基因编辑市场的要素，是疾病与其他遗传性症状的盛行率增加，对定做药的需求高涨，R&D费的成长和生物科技及医药品事业的开拓，民间及公共部门的资金筹措增加，定序的迅速进步，基因编辑的发展等。

本报告提供全球基因编辑的市场调查，市场概要，市场的各种影响因素的分析，技术、革新趋势，市场规模的变化、预测，各种区分、各地区的明细，竞争情形，主要企业简介等彙整资讯。

市场动态
促进因素
机会
阻碍因素
课题
法规情形
SWOT分析
波特分析
未来阻碍相关Skyquest的特别洞察
全球基因编辑市场:各技术
Meganucleases
CRISPR/CAS9、Talens/Megatals、Zfn
全球基因编辑市场:各输送手法
Ex-vivo
In-vivo
全球基因编辑市场:各模式
委託
公司内部
全球基因编辑市场:各终端用户
生物科技企业、製药公司
学术及政府研究机关
CRO

市场规模:各地区

北美
美国
加拿大
欧洲
德国
西班牙
法国
英国
其他的欧洲
亚太地区
中国
印度
日本
韩国
其他的亚太地区
南美
巴西
其他的南美
中东、非洲
GCC各国
南非
其他的中东、非洲

主要企业简介

前五名公司的比较
主要企业的地位
主要企业的采用策略
主要成功策略
市场上最近的活动
主要企业的市场占有率
Merck KGaA
Cibus, Recombinetics, Inc.
Sangamo
Editas Medicine
Precision Biosciences
Ccispr Therapeutics
Intellia Therapeutics, Inc.
Caribou Biosciences, Inc.
Cellectis S.A.
AstraZeneca
Takara Bio USA
Horizon Discovery Group plc
Integrated DNA Technologies, Inc.
Egenesis Inc.
GenScript
New England Biolabs
OriGene Technologies, Inc.
Lonza
Thermo Fisher Scientific, Inc.

简介目录

Product Code: SQSG35J2001

Genome Editing Market size was valued at USD 4811.04 million in 2021 and is poised to grow from USD 5887.06 million in 2022 to USD 36060.95 million by 2030, growing at a CAGR of 22.3% in the forecast period (2023-2030).

A method for altering the DNA of a cell or an organism is genome editing. DNA sequences are cut during the procedure to add or remove DNA from the genome. The genome is modified to provide the cell the characteristics it requires. In order to support genome-altering research, numerous governments throughout the world are increasing their resources and grants. Due to the advantages of genome editing, governments are also funding public and commercial research as well as academic foundations to broaden the study of genome editing and hereditary designing. This results in the positive growth of the Genome Editing Market during the time of forecasting.

Factors driving the genome editing market include the increasing prevalence of disease and other hereditary conditions, growing demand for customised medications, growth in R&D spending and biotechnology and pharmaceutical business development, rise in private and public sector funding, rapid advances in sequencing, and developments in genome editing.

In recent years, the market has grown primarily due to the increased demand for synthetic genes in a range of biotechnology fields and the expanding use of CRISPR genome editing technology.

Due to the growing number of applications for genome editing tools, there is also more competition among market participants in the genome editing industry. More focus has been placed on the flexible CRISPR technology. For instance, Vertex Pharmaceuticals paid CRISPR Therapeutics USD 900 million in April 2021 for the development, production, and marketing of CRISPR-Cas9 gene-edited therapies for beta-thalassemia and sickle cell disease. These measures should accelerate the expansion of the genome editing market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genome Editing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global Genome Editing Market is segmented based on Technology, Delivery Method, Mode, End-use, Application, and Region. Based on Technology it is categorized into CRISPR, TALEN, ZFN, Antisense, and Other Technologies. Based on the Delivery Method it is categorized into Ex-vivo and In-vivo. Based on Mode it is categorized into Contract, In-house. Based on End-use it is categorized into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations. Based on the Region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

In recent years, governments from many different nations have made large investments in the science of genomics, which has greatly aided the development of novel genome editing tools. In-depth genome engineering/editing research has also been made possible by the availability of government funding for university and government institutions. For instance, in March 2020, the Ministry of Innovation, Science, and Industry (Science) announced a USD 15 million grant to Genome Canada to fund 11 genomic research initiatives in the fields of health, agriculture, and the environment. These projects will receive a combined investment of USD 29.7 million from provincial governments, companies, and research partners. Among the initiatives is research into cervical and ovarian cancer. Due to large government investments in genomics, the number of genomics research programmes has expanded significantly. Therefore, growth in the genome editing market is anticipated during the course of the forecast period.

The market will grow due of how simple CRISPR/CAS9 is to employ. Compared to other methods of genome editing, this technology area is straightforward and reasonably priced.Through the application of gene editing technology, cancer can be treated with this method.

Restraint

Off-target effects of CRISPR-Cas9 are a significant worry. However, because Cas9 causes double-stranded breaks, any off-target nuclease activity can lead to changes in these genes, which may result in oncogenesis. When there are one to three mismatches in the target, CRISPR-Cas9 can tolerate them without producing off-target nuclease activity. The high frequency of off-target activity (50%)-mutations at locations other than the targeted on-target location-is another significant cause for concern. For instance, CRISPR can turn on the cancer-causing gene or target the genes that limit tumour growth. This adverse consequence has caused problems for numerous companies organising clinical trials. In order to increase the safety of this procedure, clinical studies have been stopped, and regulatory authorities are recommending more research.

The sophisticated features and functionality of genomic instruments are a key factor in their high price. It costs between $10 million and $20 million dollars. Pharmaceutical businesses and small- and medium-sized laboratories cannot afford the equipment at these high prices. It could be a significant barrier to the market's growth.

Market Trends

Major pharmaceutical, biotechnology, and genomic companies have all made investments in vaccine research and development as a result of the COVID-19 pandemic. The demand for vaccinations and potential antiviral treatments has brought genome editing/engineering technologies to the fore; these reasons are anticipated to propel the genome editing market in the years to come.

In comparison to traditional diagnostic or therapeutic approaches, molecular biology techniques like SHERLOCK, DETECTOR, CARVER and PAC-MAN based on CRISPR-Cas12/13, antisense peptide nucleic acids, ribozymes, aptamers, and RNAi silencing therapies, as well as antisense peptide nucleic acids, aptamers, and aptamers, proven crucial in COVID-19 outbreaks. Such aspects have emerged as significant drivers and are anticipated to propel the Genome Editing Market over the projected year. These technologies served as modern diagnostic and therapeutic approaches, from quicker and simpler diagnosis to more focused virus detection and elimination.

Executive Summary

Market overview

Exhibit: Executive Summary - Chart on Market Overview
Exhibit: Executive Summary - Data Table on Market Overview
Exhibit: Executive Summary - Chart on Global Genome Editing Characteristics
Exhibit: Executive Summary - Chart on Market by Geography
Exhibit: Executive Summary - Chart on Market Segmentation
Exhibit: Executive Summary - Chart on Incremental Growth
Exhibit: Executive Summary - Data Table on Incremental Growth
Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

Market Dynamics
Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
SWOT Analysis

KEY MARKET INSIGHTS

Technology Analysis
(Exhibit: Data Table: Name of technology and details)
Pricing Analysis
(Exhibit: Data Table: Name of technology and pricing details)
Supply Chain Analysis
(Exhibit: Detailed Supply Chain Presentation)
Value Chain Analysis
(Exhibit: Detailed Value Chain Presentation)
Ecosystem Of the Market
Exhibit: Parent Market Ecosystem Market Analysis
Exhibit: Market Characteristics of Parent Market
IP Analysis
(Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
Trade Analysis
(Exhibit: Data Table: Import and Export data details)
Startup Analysis
(Exhibit: Data Table: Emerging startups details)
Raw Material Analysis
(Exhibit: Data Table: Mapping of key raw materials)
Innovation Matrix
(Exhibit: Positioning Matrix: Mapping of new and existing technologies)
Pipeline product Analysis
(Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
Macroeconomic Indicators

COVID IMPACT

Introduction
Impact On Economy-scenario Assessment
Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
Revised Market Size
Exhibit: Data Table on Global Genome Editing size and forecast 2021-2027 ($ million)
Impact Of COVID On Key Segments
Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
COVID Strategies By Company
Exhibit: Analysis on key strategies adopted by companies